Study of 14 cases of brucellosis in employees of a meat packing plant as a professional disease

Uruguay 2009-2010

  • Adriana Pisani Universidad de la República. Prof. Adjunta del Departamento de Salud Ocupacional. Especialista en Salud Ocupacional
  • Mariela Vacarezza Universidad de la República. Facultad de Medicina. Ex Prof. Adj. de Enfermedades Infecciosas y Medicina Interna. Especialista en Enfermedades Infecciosas. Especialista en Medicina Interna
  • Fernando Tomasina Universidad de la República. . Facultad de Medicina. Profesor del Departamento de Salud Ocupacional
Keywords: BRUCELLOSIS, WORKING CONDITIONS

Abstract

The present study was carried out on 14 workers from the same meat packing plant industry who contracted brucellosis, diagnosed and assisted in the context of accident and occupational disease insurance in our country. They attended the labor medicine clinic of the Department of Occupational Health, Hospital de Clínicas, during the years 2009-2010 for advice on occupational health.

The objective of the present study was to describe and characterize the working conditions and clinical manifestations of the 14 workers of the same company with a diagnosis of brucellosis who consulted the Department’s polyclinic during the period covered by the review.

For this, a descriptive study was performed based on a pre-existing source provided by workers diagnosed with brucellosis. The interviews were carried out in the outpatient clinic of the Department of Occupational Health, from January 2009 to July 2010. The data obtained from the clinical histories provided by those involved and from the work history were they entered a statistical base (EPI info 2000).

Of the 14 individuals studied, two women and 12 men presented as more frequent symptoms: asthenia, myalgias, fever, arthralgia, sweating and headaches. Eight of the workers belonged to the work sector, 3 to mondonguería, viscera and corrals, 2 to cleaning and 1 to maintenance. The time of year where the highest numbers of cases were observed was January, February and March of 2009, which coincides with an increase in the slaughter of animals. The time of assistance was prolonged, coincides with other works consulted.

Conclusions:

the characteristics of the labor process and the presence of the biological agent in the environment are determinant in the appearance of the disease in exposed workers. The fundamental pillars in the prevention of this disease, are based on the training of workers and employers.

Improvements in the overall work environment and the conditions under which the task is performed are essential, as a link between the process and the probable damage to health.

References

(1) España. Instituto Nacional de Seguridad e Higiene en el trabajo. NTP 411: zoonosis de origen laboral. Madrid: INSHT, 1999. Disponible en: Disponible en: http://www.insht.es/InshtWeb/Contenidos/Documentacion/FichasTecnicas/NTP/Ficheros/401a500/ntp_411.pdf . Consulta: 20 mayo 2017.

(2) Uruguay. Ministerio de Ganadería Agricultura y Pesca. Dirección General de Servicios Ganaderos. Brucelosis bovina. Montevideo: DGSG, 2016. Disponible en: Disponible en: http://www.mgap.gub.uy/unidad-ejecutora/direccion-general-de-servicios-ganaderos/informacion-tecnica/brucelosis-bovina/brucelosis . Consulta: 20 mayo 2017.

(3) Organización Panamericana de la Salud. Brucelosis. Washington DC: OPS, 2015. Disponible en: Disponible en: http://www.paho.org/panaftosa/index.php?option=com_content&view=article&id=184:brucelosis&catid=741:aft-04-projetos-e-programas . Consulta: 23 mayo 2017.

(4) Uruguay. Ministerio de Salud. División de Epidemiología. Departamento de Vigilancia en Salud. Enfermedades de notificación obligatoria 2011. Montevideo: MSP, 2011. Disponible en: Disponible en: http://www.msp.gub.uy/sites/default/files/enf_notificacion_obligatoria_2011.pdf . Consulta: 24 mayo 2017.

(5) Uruguay. Ministerio de Salud. División de Epidemiología. Departamento de Vigilancia en Salud. Enfermedades de notificación obligatoria 2012. Montevideo: MSP , 2012. Disponible en: http://www.msp.gub.uy/sites/default/files/Enf_notificacion_obligatoria_acumulado_2012.pdf. Consulta: 24 mayo 2017.

(6) Purriel P. Aspectos epidemiológicos y clínicos de la brucelosis en Uruguay. Bol Oficina Sanit Panam 1959; 46(2):118-35. Disponible en: Disponible en: http://hist.library.paho.org/Spanish/BOL/v46n2p118.pdf . Consulta: 25 mayo 2017.

(7) Pila Pérez R, Pila Peláez R, Basulto MP, Hernández Pupo O, García Peña J, Torres Vadella G. Estudio clínico de la brucelosis humana. Rev Méd Urug 1997; 13(2):110-7. Disponible en: Disponible en: http://www.rmu.org.uy/revista/1997v2/art5.pdf . Consulta: 25 mayo 2017.

(8) Estados Unidos. Biblioteca Nacional de Medicina. Medline plus: brucelosis. Bethesda, MD: NLM, 2015. Disponible en: Disponible en: https://medlineplus.gov/spanish/ency/article/000597.htm . Consulta: 24 mayo 2017.

(9) Ariza J. Brucelosis en el siglo XXI. Med Clin (Barc) 2002; 119(9):339-44.

(10) López Guarnizo P. Estudio descriptivo de la presentación de brucelosis humana en Colombia desde 2000 hasta 2012. Rev Med Vet (Bogotá) 2014; 28:67-79. Disponible en: Disponible en: http://www.scielo.org.co/pdf/rmv/n28/n28a07.pdf . Consulta: 24 mayo 2017.

(11) Young EJ. Serologic diagnosis of human brucellosis: analysis of 214 cases by agglutination tests and review of the literature. Rev Infect Dis 1991; 13(3):359-72.

(12) Morales Ortegon D, Combariza Bayona DA. Seroprevalencia de brucelosis en trabajadores de mataderos de municipios del Tolima (Colombia). Rev Cienc Salud (Bogotá) 2004; 2(1):15-23. Disponible en: Disponible en: http://revistas.urosario.edu.co/index.php/revsalud/article/view/782 . 24 mayo 2017.

(13) Navarro Rodríguez A, Betton Díaz J, Torronteras SR, Cuello Contreras J, Viciana Fernández P, López Contreras L, et al. Utilidad del test de inmunofluorescencia indirecta y la prueba de la «rosa de Bengala» en el diagnóstico de la brucelosis. Rev Clin Esp 1984; 175(1):27-32.

(14) Márquez Jaca S, Díaz Rodríguez DR, Sánchez Camara RL , Menendez Bernal HA, Verga Tirado B. Riesgo de brucelosis en humanos: diseño de un sistema de vigilancia. Rev Ciencias Médicas 2012; 16(2):107-23. Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-31942012000200009 . Consulta: 25 mayo 2017.

(15) Castro HA, González SR, Prat MI. Brucelosis: una revisión práctica. Acta Bioquím Clín Latinoam 2005; 39(2):203-16. Disponible en: Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-29572005000200008. Consulta: 25 mayo 2017.

(16) Quintero G, Calderón A, Rodríguez V, Barrios C, Yasnot MF, Villadiego M. Determinación de la seroprevalencia de anticuerpos para Brucella abortus en trabajadores de un frigorífico y ordeñadores en montería, Córdoba (Colombia). Rev UDCA Actual Divulg Cient 2014; 17(2):333-40. Disponible en: Disponible en: http://www.scielo.org.co/scielo.php?pid=S0123-42262014000200004&script=sci_abstract&tlng=es . Consulta: 25 mayo 2017.

(17) Yousefi-Nooraie R, Mortaz-Hejri S, Mehrani M, Sadeghipour P. Antibiotics for treating human brucellosis. Cochrane Database Syst Rev 2012; 10:CD007179.

(18) Alavi SM, Alavi L. Treatment of brucellosis: a systematic review of studies in recent twenty years. Caspian J Intern Med 2013; 4(2):636-41.

(19) Falagas ME, Bliziotis IA. Quinolones for treatment of human brucellosis: critical review of the evidence from microbiological and clinical studies. Antimicrob Agents Chemother 2006; 50(1):22-33. Disponible en: http://aac.asm.org/content/50/1/22.long. Consulta: 25 mayo 2017.

(20) Roushan MR, Amiri MJ, Janmohammadi N, Hadad MS, Javanian M, Baiani M, et al. Comparison of the efficacy of gentamicin for 5 days plus doxycycline for 8 weeks versus streptomycin for 2 weeks plus doxycycline for 45 days in the treatment of human brucellosis: a randomized clinical trial. J Antimicrob Chemother 2010; 65(5):1028-35.

(21) Ariza J, Gudiol F, Pallarés R, Rufí G, Fernández-Viladrich P. Comparative trial of rifampin-doxycycline versus tetracycline-streptomycin in the therapy of human brucellosis. Antimicrob Agents Chemother 1985; 28(4):548-51. Disponible en: Disponible en: http://pubmedcentralcanada.ca/pmcc/articles/PMC180303/pdf/aac00176-0098.pdf . Consulta: 25 mayo 2017.

(22) Hashemi SH, Gachkar L, Keramat F, Mamani M, Hajilooi M, Janbakhsh A, et al. Comparison of doxycycline-streptomycin, doxycycline-rifampin, and ofloxacin-rifampin in the treatment of brucellosis: a randomized clinical trial. Int J Infect Dis 2012; 16(4):e247-51.

(23) Suárez R, Lomello V, Giovannini F. Análisis de riesgo económico del saneamiento de la brucelosis bovina en rodeos de cría. Anales de la XXXIII Reunión Anual de Economía Agraria. Bs. As., Argentina: 23-25 de octubre 2002.

Published
2019-07-15
How to Cite
1.
Pisani A, Vacarezza M, Tomasina F. Study of 14 cases of brucellosis in employees of a meat packing plant as a professional disease. Rev. Méd. Urug. [Internet]. 2019Jul.15 [cited 2024Nov.15];33(3):168-73. Available from: http://www2.rmu.org.uy/ojsrmu311/index.php/rmu/article/view/97